Integrated Biomarker And Imaging Study - 2

Completed

Phase 2 Results

Main Contacts

Name Phone E-mail
GSK Clinical Trials Study Director
GSK Clinical Trials, MD Study Director

Other Locations

Name City State Country Status
GSK Investigational Site Antwerpen Belgium Unknown_status_icon
GSK Investigational Site Bad Segeberg Schleswig-Holstein Germany Unknown_status_icon
GSK Investigational Site Aalst Belgium Unknown_status_icon
GSK Investigational Site Liège Belgium Unknown_status_icon
GSK Investigational Site Praha 2 Czech Republic Unknown_status_icon
GSK Investigational Site Heidelberg Baden-Wuerttemberg Germany Unknown_status_icon
GSK Investigational Site Ulm Baden-Wuerttemberg Germany Unknown_status_icon
GSK Investigational Site Muenchen Bayern Germany Unknown_status_icon
GSK Investigational Site Eindhoven Netherlands Unknown_status_icon
GSK Investigational Site Leeuwarden Netherlands Unknown_status_icon
GSK Investigational Site Marid Spain Unknown_status_icon
GSK Investigational Site Bad Nauheim Hessen Germany Unknown_status_icon
GSK Investigational Site Essen Nordrhein-Westfalen Germany Unknown_status_icon
GSK Investigational Site Enschede Netherlands Unknown_status_icon
GSK Investigational Site Rotterdam Netherlands Unknown_status_icon
GSK Investigational Site Rotterdam Netherlands Unknown_status_icon
GSK Investigational Site Katowice Poland Unknown_status_icon
GSK Investigational Site Krakow Poland Unknown_status_icon
GSK Investigational Site Brest Cedex France Unknown_status_icon
GSK Investigational Site Vienna Austria Unknown_status_icon
GSK Investigational Site Aarhus N Denmark Unknown_status_icon
GSK Investigational Site Hamburg Germany Unknown_status_icon
GSK Investigational Site Bergen Norway Unknown_status_icon
GSK Investigational Site Santander Spain Unknown_status_icon
GSK Investigational Site Luzern 16 Switzerland Unknown_status_icon
GSK Investigational Site Besancon France Unknown_status_icon